APGE logo

Apogee Therapeutics, Inc. (APGE) EBIT

annual EBIT:

-$216.87M-$123.87M(-133.19%)
December 31, 2024

Summary

  • As of today (September 16, 2025), APGE annual earnings before interest & taxes is -$216.87 million, with the most recent change of -$123.87 million (-133.19%) on December 31, 2024.
  • During the last 3 years, APGE annual EBIT has fallen by -$186.24 million (-607.92%).
  • APGE annual EBIT is now -607.92% below its all-time high of -$30.64 million, reached on December 31, 2022.

Performance

APGE EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEincome statement metrics

quarterly EBIT:

-$73.17M-$10.07M(-15.96%)
June 30, 2025

Summary

  • As of today (September 16, 2025), APGE quarterly earnings before interest & taxes is -$73.17 million, with the most recent change of -$10.07 million (-15.96%) on June 30, 2025.
  • Over the past year, APGE quarterly EBIT has dropped by -$29.04 million (-65.82%).
  • APGE quarterly EBIT is now -3928.91% below its all-time high of -$1.82 million, reached on June 1, 2022.

Performance

APGE quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEincome statement metrics

TTM EBIT:

-$270.83M-$29.04M(-12.01%)
June 30, 2025

Summary

  • As of today (September 16, 2025), APGE TTM earnings before interest & taxes is -$270.83 million, with the most recent change of -$29.04 million (-12.01%) on June 30, 2025.
  • Over the past year, APGE TTM EBIT has dropped by -$127.06 million (-88.39%).
  • APGE TTM EBIT is now -6191.01% below its all-time high of -$4.30 million, reached on March 1, 2022.

Performance

APGE TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

APGE EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-133.2%-65.8%-88.4%
3 y3 years-607.9%-3928.9%-4324.6%
5 y5 years-607.9%-1599.5%-6191.0%

APGE EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-607.9%at low-3928.9%+3.6%-4324.6%at low
5 y5-year-607.9%at low-3928.9%+3.6%-6191.0%at low
alltimeall time-607.9%at low-3928.9%+3.6%-6191.0%at low

APGE EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$73.17M(+16.0%)
-$270.83M(+12.0%)
Mar 2025
-
-$63.10M(-16.8%)
-$241.78M(+11.5%)
Dec 2024
-$216.87M(+133.2%)
-$75.88M(+29.3%)
-$216.87M(+21.7%)
Sep 2024
-
-$58.69M(+33.0%)
-$178.14M(+23.9%)
Jun 2024
-
-$44.12M(+15.6%)
-$143.76M(+21.3%)
Mar 2024
-
-$38.18M(+2.8%)
-$118.53M(+27.4%)
Dec 2023
-$93.00M
-$37.16M(+52.9%)
-$93.00M(+66.5%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$24.30M(+28.7%)
-$55.85M(+32.8%)
Jun 2023
-
-$18.89M(+49.2%)
-$42.05M(+68.3%)
Mar 2023
-
-$12.66M(+20.5%)
-$24.98M(+50.2%)
Dec 2022
-$30.64M
-
-
Sep 2022
-
-$10.51M(+478.6%)
-$16.63M(+171.7%)
Jun 2022
-
-$1.82M(-57.8%)
-$6.12M(+42.2%)
Mar 2022
-
-$4.30M
-$4.30M

FAQ

  • What is Apogee Therapeutics, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. annual EBIT year-on-year change?
  • What is Apogee Therapeutics, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. quarterly EBIT year-on-year change?
  • What is Apogee Therapeutics, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Apogee Therapeutics, Inc.?
  • What is Apogee Therapeutics, Inc. TTM EBIT year-on-year change?

What is Apogee Therapeutics, Inc. annual earnings before interest & taxes?

The current annual EBIT of APGE is -$216.87M

What is the all time high annual EBIT for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$30.64M

What is Apogee Therapeutics, Inc. annual EBIT year-on-year change?

Over the past year, APGE annual earnings before interest & taxes has changed by -$123.87M (-133.19%)

What is Apogee Therapeutics, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of APGE is -$73.17M

What is the all time high quarterly EBIT for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$1.82M

What is Apogee Therapeutics, Inc. quarterly EBIT year-on-year change?

Over the past year, APGE quarterly earnings before interest & taxes has changed by -$29.04M (-65.82%)

What is Apogee Therapeutics, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of APGE is -$270.83M

What is the all time high TTM EBIT for Apogee Therapeutics, Inc.?

Apogee Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$4.30M

What is Apogee Therapeutics, Inc. TTM EBIT year-on-year change?

Over the past year, APGE TTM earnings before interest & taxes has changed by -$127.06M (-88.39%)
On this page